Share on StockTwits

Shares of CVS Caremark (NYSE:CVS) have been given an average rating of “Buy” by the twenty-two analysts that are presently covering the company, AmericanBankingNews.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $78.75.

CVS Caremark (NYSE:CVS) opened at 77.81 on Wednesday. CVS Caremark has a 1-year low of $56.32 and a 1-year high of $79.43. The stock’s 50-day moving average is $76.93 and its 200-day moving average is $74.29. The company has a market cap of $90.260 billion and a P/E ratio of 18.66.

CVS Caremark (NYSE:CVS) last released its earnings data on Tuesday, August 5th. The company reported $1.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter last year, the company posted $0.97 earnings per share. CVS Caremark’s revenue was up 10.7% compared to the same quarter last year. On average, analysts predict that CVS Caremark will post $4.49 EPS for the current fiscal year.

A number of analysts have recently weighed in on CVS shares. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of CVS Caremark in a research note on Wednesday. They now have a $91.00 price target on the stock, up previously from $82.00. Separately, analysts at Cantor Fitzgerald raised their price target on shares of CVS Caremark from $66.00 to $71.00 in a research note on Wednesday. Finally, analysts at Morgan Stanley raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday.

In other CVS Caremark news, EVP J. David Joyner sold 123,516 shares of CVS Caremark stock on the open market in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $76.10, for a total value of $9,399,567.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.